All Stories

  1. Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial

    Article • OncoTargets and Therapy, March 2016, Dove Medical Press

    Manuel Domine